Unresolved
The available records do not permit a responsible conclusion.
Monsanto said in February 2026 that a class settlement of up to US$7.25 billion would resolve current and future Roundup claims tied to non-Hodgkin lymphoma.
- About
- Bayer AG
- Claim made by
- Bayer, company statement
- Published
- 17 February 2026
- Evidence score
- 67 How it was scored
- Last reviewed
- 25 October 2026
Why this label
The settlement exists and is designed to cover current and future NHL claims, paid over up to 21 yearsS4. It contains no admission of liabilityS4. A St. Louis circuit judge granted preliminary approval in March 2026S6. Judge Timothy Boyer held a final approval hearing on 14 September 2026 and did not rule at the hearingS5S7. Opt-outs were still being evaluated and stay revocable until final approvalS5. No final approval order was found as of October 2026. Whether the settlement will resolve the claims as announced depends on that decision and on any appeals, so the records do not yet permit a conclusion.
Current procedural position
Preliminary approval granted in March 2026S6. Final approval hearing held before Judge Timothy Boyer on 14 September 2026, decision reservedS5S7. No final approval order found in a search as of 25 October 2026.
Record supporting the assessment
The class settlement is designed to resolve claims relating to Roundup™ exposure and NHL regardless of legal theory.
a U.S. judge granted preliminary approval for a $7.25 billion settlement proposal
Conflicting or limiting record
The Court's final approval decision is expected to come at a later time and not in conjunction with the hearing.
Opt-outs remain revokable until final approval.
Boyer is not expected to issue an immediate ruling at the hearing.
Evidence score: 67 of 100
The score grades how well the record establishes this assessment. It is not a score of Bayer AG. Score = source authority + directness + corroboration + procedural accuracy + currency + reproducibility.
| Component | Points | Max | Reason |
|---|---|---|---|
| Source authorityIs the source competent to establish the proposition? | 19 | 30 | The status rests on company statements and press reports, not the court docket. |
| DirectnessDoes the source state the proposition or only discuss adjacent facts? | 16 | 20 | The records state the settlement terms and the pending decision directly. |
| CorroborationDo independent records support the same material point? | 11 | 15 | Reuters reports on preliminary approval and the September hearing agree with Bayer's account. |
| Procedural accuracyDoes the record settle the procedural state the claim describes? | 5 | 15 | Final approval is pending and appeals are possible. |
| CurrencyHas the record been checked against later developments? | 8 | 10 | Checked to September 2026. No October 2026 ruling was found in a search. |
| ReproducibilityCan a reader locate the passage and repeat the assessment? | 8 | 10 | Bayer pages and the press report are public. The court order itself was not read. |
| Total | 67 | 100 |
Timeline
Related cases
- Roundup class plaintiffs and Monsanto CompanyCircuit Court of the City of St. Louis, Missouri. Civil. Not published.Stage: Preliminary approval granted. Final approval hearing held on 14 September 2026, decision pending.
Responses
- Monsanto Company, 17 February 2026: Monsanto said the settlement agreements contain no admission of liability or wrongdoing and that it acted to contain the litigation.S4
Revision history
- Assessment first published with label Unresolved.
Have a record that changes this assessment? See corrections and responses.
Sources
- S4Tier B Monsanto announces Roundup™ class settlement agreement to resolve current and future claimsBayer. Company statement. 17 February 2026.Company account of the settlement terms and its view of regulators' conclusions. It is not a court record.
- S6Tier C Bayer Wins Court Nod for $7.25 Billion Roundup SettlementClaims Journal. Press report. 5 March 2026.Report by Sonja Wind on preliminary approval by St. Louis Circuit Judge Tim Boyer and the 4 June opt-out deadline. It does not cover final approval.Link working, checked 25 October 2026
- S5Tier B Roundup™ LitigationBayer. Company statement. 11 August 2026, modified 17 September 2026.Company statement that the final approval hearing took place on 14 September 2026 and the decision will come later. It does not report a ruling.
- S7Tier C Bayer’s Monsanto unit urges Missouri judge to approve $7.25 billion Roundup settlementReuters (via Investing.com). Press report. 14 September 2026.Report by Dietrich Knauth on the final approval hearing before Judge Timothy Boyer. It confirms no ruling was expected at the hearing. It does not report a later decision.Link working, checked 25 October 2026
Other claims about Bayer AG
- Unresolved66Plaintiffs in US Roundup lawsuits have claimed that exposure to the glyphosate-based herbicide Roundup causes non-Hodgkin lymphoma in humans.Court filing, 25 June 20264 records citedProduct claims
- Partly supported77Monsanto said in February 2026 that regulators, including the US EPA and EU bodies, conclude that glyphosate-based herbicides can be used safely and are not carcinogenic.Company statement, 17 February 20264 records citedProduct claims
- Outdated86The US EPA's February 2020 interim registration review decision found that glyphosate is unlikely to be a human carcinogen.Regulator statement, February 20203 records citedProduct claims
- Supported95The US Supreme Court held in June 2026 that federal pesticide law preempts a Missouri Roundup user's failure-to-warn claim against Monsanto.Court filing, 25 June 20263 records citedCorporate status